A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2001
11/15/2001	CA2407830A1 Amino acid derivatives and their use as medicines
11/15/2001	CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/14/2001	EP1153618A1 Use of oxidized cellulose as free radical scavenger
11/14/2001	EP1153610A1 Matrix protein compositions for inflammatory and infectious conditions
11/14/2001	EP1153601A1 Skin preparations for external use
11/14/2001	EP1153125A1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
11/14/2001	EP1153038A1 Therapeutics and diagnostics based on a il-1b mutation
11/14/2001	EP1152770A1 Small peptides and methods for treatment of asthma and inflammation
11/14/2001	EP1152768A2 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)
11/14/2001	EP1152761A2 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases
11/14/2001	EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
11/14/2001	EP1152748A1 Method and composition for treating acne
11/14/2001	EP1152745A2 Synergistic antimicrobial skin washing compositions
11/14/2001	EP1152744A1 Skin sanitizing compositions
11/14/2001	EP1152743A1 Skin sanitizing compositions
11/14/2001	EP1152734A1 Modified calycins
11/14/2001	EP1152731A1 A skin care composition that mediates cell to cell communication
11/14/2001	EP1152723A1 Enzymatic treatment and prevention of hypertrophic skin
11/14/2001	EP1003537B1 Composition comprising propolis and at least an essential oil
11/14/2001	EP0956016A4 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
11/14/2001	EP0815087B1 Trisubstituted phenyl derivatives
11/14/2001	EP0777482B1 Combined preparation for the therapy of immune diseases
11/14/2001	EP0763037B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
11/14/2001	EP0672041B1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
11/14/2001	CN1322246A Restin and methods of use thereof
11/14/2001	CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists
11/14/2001	CN1322194A Substituted phenyl derivatives, their preparation and use
11/14/2001	CN1322138A Protease inhibitors for use in treatment of psoriasis
11/14/2001	CN1322134A Naphthalenecarboxamides as tachykinin receptor antagonists
11/14/2001	CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma
11/14/2001	CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001	CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001	CN1321500A Method for preventing and curing diseases by using kakonein preparation
11/14/2001	CN1321498A Medicine for curing acne and sore
11/14/2001	CN1321497A Preparation method of foot-immersing liquid medicine
11/14/2001	CN1321495A Medicine for eliminating freckle and acne
11/14/2001	CN1321487A Beauty face-nourishing capsule
11/14/2001	CN1321482A Medicine for curing genital ulcer and dermatosis for external application
11/14/2001	CN1321478A Chinese medicine liniment for external application for curing psoriasis
11/14/2001	CN1321466A Biopharmaceutical composition for eliminating cutaneous nevus, verruca and wart and its preparation method
11/14/2001	CN1321465A Dermatitis treating medicine
11/14/2001	CN1074675C Chinese medicine composition for producing domestic chemical product
11/14/2001	CN1074667C Medicine for treating wound
11/13/2001	US6316642 For therapy of osteoporosis and psoriasis, as anticancer agent
11/13/2001	US6316502 Administering disulfide derivative of dithiocarbamate compound to bind to iron
11/13/2001	US6316478 IL-8 receptor antagonists
11/13/2001	US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001	US6316461 Antipruritic
11/13/2001	US6316456 Purine derivatives having, in particular, antiproliferative properties, and their biological uses
11/13/2001	US6316444 SRC kinase inhibitor compounds
11/13/2001	US6316030 Use of nanoscale sterols and sterol esters
11/13/2001	US6316021 Extensible mask including an adhesive matrix that can be stretched at least in the wet state
11/13/2001	US6316012 Cosmetic or pharmaceutical composition comprising, in combination, a peroxidase and an anti-singlet oxygen agent
11/13/2001	US6316009 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharamaceutical and cosmetic compositions containing same
11/13/2001	US6315978 Bioconjugates and delivery of bioactive agents
11/12/2001	CA2347442A1 Free radical scavenging compositions
11/11/2001	CA2345787A1 Biocompatible macromers
11/10/2001	CA2347151A1 Method for screening a substance having promoting activity on hair growth
11/08/2001	WO2001083775A2 Proteases
11/08/2001	WO2001083740A2 Splice-region antisense composition and method
11/08/2001	WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	WO2001083554A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083547A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083543A1 Human wingless-like gene
11/08/2001	WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents
11/08/2001	WO2001083512A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto
11/08/2001	WO2001083510A1 29 human secreted proteins
11/08/2001	WO2001083489A1 THIENO[2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS
11/08/2001	WO2001083462A1 Novel, slow-acting betamimetics, a method for their production and their use as medicaments
11/08/2001	WO2001083450A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
11/08/2001	WO2001083438A2 New gamma selective retinoids
11/08/2001	WO2001083031A2 Topical composition for the treatment of psoriasis and related skin disorders
11/08/2001	WO2001082975A2 Membrane-permeant peptide complexes for medical imaging
11/08/2001	WO2001082956A1 Pharmaceutical composition
11/08/2001	WO2001082953A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
11/08/2001	WO2001082952A2 USE OF α-MSH AND EPO FOR PREVENTING OR TREATING ISCHEMIC CONDITIONS
11/08/2001	WO2001082940A1 Plant extract of the olea europaea species as no-synthase inhibitor and uses
11/08/2001	WO2001082937A1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
11/08/2001	WO2001082899A2 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
11/08/2001	WO2001082888A1 Lipochroman-6 as no-synthase inhibitor and uses
11/08/2001	WO2001082887A1 Plant extract of the species vitis vinifera as no-synthase inhibitor and uses
11/08/2001	WO2001082885A1 Cosmetic and/or pharmaceutical preparations that contain an extract of the plant argania spinosa
11/08/2001	WO2001082863A2 Polyacid/polyalkylene oxide foams and gels and methods for their delivery
11/08/2001	WO2001068070A8 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
11/08/2001	WO2001060349A3 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof.
11/08/2001	WO2001044242A9 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases
11/08/2001	WO2001041776A3 Use of honey in medical dressings
11/08/2001	WO2001041760A3 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/08/2001	WO2001040460A8 Screening method for compounds capable of modularing egr-1-regulated expression
11/08/2001	WO2001039777A8 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof
11/08/2001	WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
11/08/2001	WO2001034183A3 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2001030383A3 Medicament in order to induce tolerance
11/08/2001	WO2001008707A3 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/08/2001	WO2000017133A3 Lta4 hydrolase inhibitors
11/08/2001	US20010039289 Antagonists; especially sodium salts
11/08/2001	US20010039274 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease
11/08/2001	US20010039273 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
11/08/2001	US20010039271 For treatment of male erectile dysfunction, female sexual dysfunction

1 ... 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 ... 1065